Stay updated on COX & EGFR Inhib. in Polyposis Clinical Trial
Sign up to get notified when there's something new on the COX & EGFR Inhib. in Polyposis Clinical Trial page.

Latest updates to the COX & EGFR Inhib. in Polyposis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdds Utah as a study location under a new Locations section, affecting participation information. Removes the Utah Locations entry and the HHS Vulnerability Disclosure, and updates the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe PubMed publications note now states entries are automatically populated from PubMed and may not all pertain to the study, and the page shows Revision: v3.3.2 (replacing the previous wording about PubMed being auto-generated by the NCT number).SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the site-wide government funding and operating status notice from the page. The change does not affect the study details, eligibility criteria, or results on this ClinicalTrials.gov record.SummaryDifference0.4%

- Check65 days agoChange DetectedNo significant additions or deletions were detected on the page; the content and layout appear unchanged.SummaryDifference0.4%

- Check94 days agoChange Detected- Added a government funding and operating status notice and updated to version v3.2.0. - Removed the resource 'Genetic and Rare Diseases Information Center resources: Classic familial adenomatous polyposis' and old revision reference v3.1.0.SummaryDifference4%

- Check101 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to COX & EGFR Inhib. in Polyposis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COX & EGFR Inhib. in Polyposis Clinical Trial page.